WithdrawnPHASE2, PHASE3NCT04147871
Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children
Studying Disorder of amino acid absorption and transport
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Advicenne Pharma
- Principal Investigator
- Luc-André GranierAdvicenne Pharma
- Intervention
- ADV7103(drug)
- Eligibility
- 70 years · All sexes
- Timeline
- 2024 – 2025
Study locations (12)
- Cliniques Universitaires Saint-Luc, Brussels, Brussels Capital, Belgium
- UZ Leuven, Gasthuisberg Hospital, Leuven, Leuven, Belgium
- CHU Grenoble, Grenoble, Grenoble Cedex, France
- CHRU Lille, Lille, Lille, France
- CHU Pitié-Salpétrière, Paris, Paris, France
- Hôpital Necker AP-HP, Paris, Paris, France
- Hôpital Necker Enfants Malades, Paris, Paris, France
- Hôpital Ténon - Explorations fonctionnelles Mutlidisciplinaires et INSERM UMR S 1155, Paris, Paris, France
- Hôpital Américain CHU de Reims, Reims, Reims, France
- CHU Reims, Reims, Reims, France
- CHU Purpan, Toulouse, Toulouse Cedex 9, France
- Centre Hospitalier Universitaire de Lyon - Hôpital Femme Mère Enfant, Bron, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04147871 on ClinicalTrials.gov